Pacific Edge shares surge after it signs agreement with FedMed, gaining access to 40M Americans

Pacific Edge shares surge after it signs agreement with FedMed, gaining access to 40M Americans
By Tina Morrison Oct. 16 (BusinessDesk) –Shares in Pacific Edge surged, making the stock the best performer on the New Zealand exchange today, after the cancer diagnostic company said it signed an agreement with US healthcare administrator FedMed which gives 40 million Americans access to its Cxbladder test to diagnose bladder tumours. Shares in Dunedin-based Pacific Edge jumped 36 percent to a five-month high of 68 cents. The deal puts Pacific Edge’s Cxbladder in front of FedMed’s preferred provider network in the US, including more than 55...